1. Jonquailine, a new pretazettine-type alkaloid isolated from Narcissus jonquilla quail, with activity against drug-resistant cancer
- Author
-
Véronique Mathieu, Xiaojie Yu, Snezna Rogelj, Marco Masi, Annelise De Carvalho, Alessio Cimmino, Alexander Kornienko, Liliya V. Frolova, Robert Kiss, Antonio Evidente, Alexander Pertsemlidis, Masi, Marco, Liliya V., Frolova, Xiaojie, Yu, Véronique, Mathieu, Cimmino, Alessio, Annelise De, Carvalho, Robert, Ki, Snezna, Rogelj, Alexander, Pertsemlidi, Alexander, Kornienko, and Evidente, Antonio
- Subjects
Stereochemistry ,Cancer cell ,Drug resistance ,Pharmacology ,Narcissus jonquilla quail ,Plant Roots ,Article ,chemistry.chemical_compound ,Alkaloids ,Cell Line, Tumor ,biology.animal ,Alkaloid ,Drug Discovery ,Narcissus jonquilla ,medicine ,Humans ,Amaryllidaceae Alkaloids ,Antiproliferative effect ,Molecular Structure ,biology ,Amaryllidaceae ,Cancer ,Narcissus ,General Medicine ,biology.organism_classification ,medicine.disease ,Antineoplastic Agents, Phytogenic ,Quail ,Jonquailine ,Paclitaxel ,chemistry ,Drug Resistance, Neoplasm - Abstract
A new alkaloid, belonging to the pretazettine group of Amaryllidaceae alkaloids, was isolated from dried bulbs of Narcissus jonquilla quail and named jonquailine. Its structure, including the absolute configuration, was elucidated using various NMR, ECD and ESI MS techniques. Initial biological evaluation revealed significant antiproliferative effects against glioblastoma, melanoma, uterine sarcoma and non-small-cell lung cancer cells displaying various forms of drug resistance, including resistance to apoptosis and multi-drug resistance. Jonquailine was also found to synergize with paclitaxel in its antiproliferative action against drug-resistant lung cancer cells. The results obtained compared with literature data also showed that the hydroxylation at C-8 is an important feature for the anticancer activity but this seems unaffected by the stereochemistry or the acetalization of the lactol.
- Published
- 2015